Rezolute (RZLT) Interest Coverage Ratio (2012 - 2026)

Rezolute (RZLT) reported Interest Coverage Ratio of 5.11 for Q1 2026, down 7.14% on a YoY basis from 5.5 in Q1 2025, and up 47.28% sequentially from 9.69 in Q4 2025.

Rezolute (RZLT) Interest Coverage Ratio (2012 - 2026) Analysis & Trends

Rezolute (RZLT) has 15 years of Interest Coverage Ratio data on file, last reported at 5.11 in Q1 2026.

  • For the quarter ending Q1 2026, Interest Coverage Ratio fell 7.14% year-over-year to 5.11; the trailing twelve-month figure through Mar 2026 stood at 25.66 (down 39.71% YoY), and the FY2025 full-year result was 0.89, up 81.58% from the prior year.
  • Interest Coverage Ratio rose to 5.11 in Q1 2026, from 9.69 in the prior quarter.
  • In the past five years, Interest Coverage Ratio ranged from a high of 0.27 in Q3 2025 to a low of 136.77 in Q2 2025.
  • A 5-year average of 35.16 and a median of 15.36 in 2022 frame the typical range for Interest Coverage Ratio.
  • Across the five-year window, Interest Coverage Ratio jumped 97.97% in 2024 and slumped 989.09% in 2025, its largest moves.
  • Tracing RZLT's Interest Coverage Ratio over 5 years: stood at 24.07 in 2022, then slumped by 82.46% to 43.91 in 2023, then jumped by 97.97% to 0.89 in 2024, then tumbled by 989.09% to 9.69 in 2025, then jumped by 47.28% to 5.11 in 2026.
  • Business Quant data shows RZLT's Interest Coverage Ratio at 5.11 in Q1 2026, 9.69 in Q4 2025, and 0.27 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 658.42
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 7.60
4 NuCana 279.75 Bn 279.75 Bn - -0.22
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 2.71
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 22.72
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -0.38
10 Rezolute 31,153.77 31,153.77 - -5.11

Historic Data

Download Data
DateValue
Mar 31, 2026 -5.11
Dec 31, 2025 -9.69
Sep 30, 2025 -0.27
Jun 30, 2025 -136.77
Mar 31, 2025 -4.77
Dec 31, 2024 -0.89
Sep 30, 2024 -0.88
Jun 30, 2024 -125.55
Mar 31, 2024 -4.50
Dec 31, 2023 -43.91
Sep 30, 2023 -23.89
Jun 30, 2023 -111.23
Mar 31, 2023 -5.85
Dec 31, 2022 -24.07
Sep 30, 2022 -61.19
Jun 30, 2022 -23.74
Mar 31, 2022 -15.36
Dec 31, 2021 -17.36
Sep 30, 2021 -10.91
Jun 30, 2021 -276.50